中文Corporate Site
Store HomeProductsCustom SynthesisScientific Resources
LoginRegister
中文Corporate Site
Store HomeProductsCustom SynthesisScientific Resources
LoginRegister
Scientific Resources

Peptide Drugs

Case studies tracing how peptide discovery hits are transformed through structural biology, medicinal chemistry, and developability optimization into drug candidates.

Search covers peptide and stable isotope technical resources.

Article Navigation
From an mRNA Display Hit to Enlicitide (1): The Story Begins with a Screen2026/10/5From an mRNA Display Hit to Enlicitide (2): Seeing How the Macrocycle Binds PCSK9 for the First Time2026/10/5From an mRNA Display Hit to Enlicitide (3): Binding Well Is Not Enough2026/10/6From an mRNA Display Hit to Enlicitide (4): How Does a Macrocyclic Peptide Begin to Become an Oral Drug?2026/10/7From an mRNA Display Hit to Enlicitide (5): From Oral Proof of Concept to a Real Drug2026/10/8

Article Navigation

From an mRNA Display Hit to Enlicitide (1): The Story Begins with a Screen2026/10/5From an mRNA Display Hit to Enlicitide (2): Seeing How the Macrocycle Binds PCSK9 for the First Time2026/10/5From an mRNA Display Hit to Enlicitide (3): Binding Well Is Not Enough2026/10/6From an mRNA Display Hit to Enlicitide (4): How Does a Macrocyclic Peptide Begin to Become an Oral Drug?2026/10/7From an mRNA Display Hit to Enlicitide (5): From Oral Proof of Concept to a Real Drug2026/10/8

Peptide Technology

From an mRNA Display Hit to Enlicitide (1): The Story Begins with a Screen

Loading article…